Katia Falasca

2.3k total citations
92 papers, 1.4k citations indexed

About

Katia Falasca is a scholar working on Epidemiology, Infectious Diseases and Emergency Medicine. According to data from OpenAlex, Katia Falasca has authored 92 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Epidemiology, 31 papers in Infectious Diseases and 24 papers in Emergency Medicine. Recurrent topics in Katia Falasca's work include HIV-related health complications and treatments (22 papers), COVID-19 Clinical Research Studies (13 papers) and HIV/AIDS drug development and treatment (12 papers). Katia Falasca is often cited by papers focused on HIV-related health complications and treatments (22 papers), COVID-19 Clinical Research Studies (13 papers) and HIV/AIDS drug development and treatment (12 papers). Katia Falasca collaborates with scholars based in Italy, United States and Greece. Katia Falasca's co-authors include Jacopo Vecchiet, Claudio Ucciferri, Eligio Pizzigallo, Paola Mancino, Marta Di Nicola, Pio Conti, Francesco Cipollone, Margherita D’Alessandro, Claudia Petrarca and Marcella Reale and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Katia Falasca

87 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katia Falasca Italy 22 421 389 241 219 200 92 1.4k
Maria Mazzitelli Italy 17 413 1.0× 352 0.9× 107 0.4× 180 0.8× 183 0.9× 109 1.1k
Francesca Ferretti Italy 23 306 0.7× 710 1.8× 114 0.5× 180 0.8× 57 0.3× 109 2.0k
Laura Richert France 24 482 1.1× 277 0.7× 259 1.1× 201 0.9× 37 0.2× 78 1.6k
Philip Abraham India 22 297 0.7× 369 0.9× 52 0.2× 253 1.2× 238 1.2× 99 1.6k
Gregory L. Austin United States 22 376 0.9× 333 0.9× 191 0.8× 576 2.6× 92 0.5× 55 2.3k
Julien Asselineau France 24 136 0.3× 657 1.7× 51 0.2× 129 0.6× 333 1.7× 52 1.7k
Snežana Brkić Serbia 17 85 0.2× 253 0.7× 68 0.3× 89 0.4× 43 0.2× 77 965
Vicente Estrada Spain 28 1.5k 3.6× 509 1.3× 1.0k 4.3× 588 2.7× 60 0.3× 113 2.6k
Dominik Jarczak Germany 18 279 0.7× 478 1.2× 133 0.6× 234 1.1× 118 0.6× 56 1.3k
Maria Velez United States 17 154 0.4× 415 1.1× 63 0.3× 70 0.3× 399 2.0× 30 1.2k

Countries citing papers authored by Katia Falasca

Since Specialization
Citations

This map shows the geographic impact of Katia Falasca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katia Falasca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katia Falasca more than expected).

Fields of papers citing papers by Katia Falasca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katia Falasca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katia Falasca. The network helps show where Katia Falasca may publish in the future.

Co-authorship network of co-authors of Katia Falasca

This figure shows the co-authorship network connecting the top 25 collaborators of Katia Falasca. A scholar is included among the top collaborators of Katia Falasca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katia Falasca. Katia Falasca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ricci, Elena, Matteo Faltoni, Giordano Madeddu, et al.. (2024). Comparison of meropenem-vaborbactam with ceftazidime-avibactam in the treatment of carbapenem-resistant Enterobacterales infections. Journal of Global Antimicrobial Resistance. 39. 4–4.
3.
Renda, Giulia, Marco Mennuni, Simona De Vecchi, et al.. (2023). Predictive Value of Echocardiographic Pulmonary to Left Atrial Ratio for In-Hospital Death in Patients with COVID-19. Diagnostics. 13(2). 224–224.
4.
Ucciferri, Claudio, et al.. (2023). Are monoclonal antibodies effective in patients with severe obesity in SARS‐CoV‐2 infected?. Immunity Inflammation and Disease. 11(2). e771–e771. 3 indexed citations
5.
Cocco, Giulio, Andrea Boccatonda, Ilaria Rossi, et al.. (2022). Early detection of pleuro‐pulmonary tuberculosis by bedside lung ultrasound: A case report and review of literature. SHILAP Revista de lepidopterología. 10(7). e05739–e05739. 7 indexed citations
6.
Ucciferri, Claudio, et al.. (2022). New Therapeutic Options in Mild Moderate COVID-19 Outpatients. Microorganisms. 10(11). 2131–2131. 6 indexed citations
7.
Dufrusine, Beatrice, Paola Lanuti, Damiana Pieragostino, et al.. (2022). Iron Dyshomeostasis in COVID-19: Biomarkers Reveal a Functional Link to 5-Lipoxygenase Activation. International Journal of Molecular Sciences. 24(1). 15–15. 10 indexed citations
8.
Ucciferri, Claudio, et al.. (2022). Molnupiravir as an Early Treatment for COVID-19: A Real Life Study. Pathogens. 11(10). 1121–1121. 9 indexed citations
9.
Falasca, Katia, et al.. (2021). It is Not Always COVID-19: Case Report about an Undiagnosed HIV Man with Dyspnea. Current HIV Research. 19(6). 548–551. 2 indexed citations
10.
Rossi, Cláudia, Paola Lanuti, Ilaria Cicalini, et al.. (2021). BNT162b2 mRNA Vaccination Leads to Long-Term Protection from COVID-19 Disease. Vaccines. 9(10). 1164–1164. 7 indexed citations
11.
Ucciferri, Claudio, et al.. (2021). Parameters associated with diagnosis of COVID‐19 in emergency department. Immunity Inflammation and Disease. 9(3). 851–861. 11 indexed citations
12.
Squillace, Nicola, Elena Ricci, Barbara Menzaghi, et al.. (2020). The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile. SHILAP Revista de lepidopterología. 1 indexed citations
13.
D’Ardes, Damiano, Lucia Esposito, Andrea Boccatonda, et al.. (2020). Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids. Microorganisms. 8(9). 1327–1327. 17 indexed citations
14.
Fabrizio, Claudia, Anna Rita Volpe, Luigia Scudeller, et al.. (2018). HIV-RNA decay in paired blood and semen samples of subjects receiving their first dolutegravir-based ART regimen. Journal of Clinical Virology. 109. 45–49. 6 indexed citations
15.
16.
Falasca, Katia, Marcella Reale, Claudio Ucciferri, et al.. (2016). Cytokines, Hepatic Fibrosis, and Antiretroviral Therapy Role in Neurocognitive Disorders HIV Related. AIDS Research and Human Retroviruses. 33(3). 246–253. 21 indexed citations
17.
Ucciferri, Claudio, Katia Falasca, Paola Mancino, Angelo Di Iorio, & Jacopo Vecchiet. (2012). Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan.. PubMed. 16(4). 491–8. 20 indexed citations
18.
Ucciferri, Claudio, Katia Falasca, Paola Mancino, Eligio Pizzigallo, & Jacopo Vecchiet. (2011). Proteinuria in an African HIV-infected patient: effects of telmisartan.. PubMed. 19(2). 125–7. 1 indexed citations
19.
Mancino, Paola, et al.. (2010). USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS. Mediterranean Journal of Hematology and Infectious Diseases. 2(1). e2010003–e2010003. 3 indexed citations
20.
Mancino, Paola, Miriana d’Alessandro, Katia Falasca, et al.. (2009). Acute urinary retention due to HSV-1: a case report.. PubMed. 17(1). 38–40. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Mazzitelli Breakdown of academic impact, for papers by Francesca Ferretti Breakdown of academic impact, for papers by Laura Richert Breakdown of academic impact, for papers by Philip Abraham Breakdown of academic impact, for papers by Gregory L. Austin Breakdown of academic impact, for papers by Julien Asselineau Breakdown of academic impact, for papers by Snežana Brkić Breakdown of academic impact, for papers by Vicente Estrada Breakdown of academic impact, for papers by Dominik Jarczak Breakdown of academic impact, for papers by Maria Velez
Rankless by CCL
2026